Daniel Paull
Daniel Paull has a total of 257 co-authors. Here are the top co-authors by number of shared publications:
Tom Rusielewicz
The New York Stem Cell Foundation Research Institute, New York, USA
8 shared publicationsChristopher J. Hunter
The New York Stem Cell Foundation Research Institute, New York, USA
6 shared publicationsJordan Goldberg
The New York Stem Cell Foundation Research Institute, New York, USA
6 shared publicationsBarry McCarthy
The New York Stem Cell Foundation Research Institute, New York, USA
5 shared publications- Bianca Migliori
Sartorius, BioAnalytics
5 shared publications Carina Seah
Pamela Sklar Division of Psychiatric Genomics, Department of Psychiatry or Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA
5 shared publications
Latest Publications
- Open Access
Patient induced pluripotent stem cells identify specificities of a reticular pseudodrusen phenotype in age-related macular degeneration
Background: Age-related macular degeneration (AMD) is a leading cause of vision loss. Reticular pseudodrusen (RPD), deposits on the apical side of the retinal pigment epithelium (RPE), signify a distinctive and critical AMD phenotype. Yet, their molecular basis and relationship to the conventional drusen seen in AMD remain unclear. Results: We generated induced pluripotent stem cell-derived RPE cells from a clinically phenotyped cohort comprising only individuals with conventional drusen (AMD/RPD−) or drusen coexisting with RPD (AMD/RPD+). From these cells, we generated single-cell transcriptomics, proteomics, and functional data to identify differences between the two cohorts. We show that AMD/RPD+ RPE cells exhibit enrichment in extracellular matrix (ECM) remodelling, cytoskeletal, and hypoxia-responsive programs, whereas AMD/RPD− RPE cells display a relatively greater representation of mitochondrial and protein homeostasis pathways. Both subtypes engaged pathways classically linked to ageing, including ECM remodelling and mitochondrial function, but differed in the direction and extent of these changes. Expression and protein quantitative trait loci (QTLs) highlight shared genetic influences on mitochondrial and iron-handling pathways, while disease-interacting eQTLs and transcriptome-wide association study identify regulatory signals that are distinctive of the RPD subtype within AMD, including through regulation of ECM. Functionally, all iPSC-derived RPE formed drusen-like deposits in vitro : AMD/RPD−lines generated more basal deposits, whereas AMD/RPD+ cells exhibited greater structural instability under bisretinoid-induced stress. Conclusions: These findings indicate that AMD with and without RPD represent mechanistically distinct entities and provide novel insight into the molecular mechanisms underlying disease heterogeneity in AMD.
Open AccessPatient induced pluripotent stem cells identify specificities of a reticular pseudodrusen phenotype in age-related macular degeneration
Background: Age-related macular degeneration (AMD) is a leading cause of vision loss. Reticular pseudodrusen (RPD), deposits on the apical side of the retinal pigment epithelium (RPE), signify a distinctive and critical AMD phenotype. Yet, their molecular basis and relationship to the conventional drusen seen in AMD remain unclear. Results: We generated induced pluripotent stem cell-derived RPE cells from a clinically phenotyped cohort comprising only individuals with conventional drusen (AMD/RPD−) or drusen coexisting with RPD (AMD/RPD+). From these cells, we generated single-cell transcriptomics, proteomics, and functional data to identify differences between the two cohorts. We show that AMD/RPD+ RPE cells exhibit enrichment in extracellular matrix (ECM) remodelling, cytoskeletal, and hypoxia-responsive programs, whereas AMD/RPD− RPE cells display a relatively greater representation of mitochondrial and protein homeostasis pathways. Both subtypes engaged pathways classically linked to ageing, including ECM remodelling and mitochondrial function, but differed in the direction and extent of these changes. Expression and protein quantitative trait loci (QTLs) highlight shared genetic influences on mitochondrial and iron-handling pathways, while disease-interacting eQTLs and transcriptome-wide association study identify regulatory signals that are distinctive of the RPD subtype within AMD, including through regulation of ECM. Functionally, all iPSC-derived RPE formed drusen-like deposits in vitro : AMD/RPD−lines generated more basal deposits, whereas AMD/RPD+ cells exhibited greater structural instability under bisretinoid-induced stress. Conclusions: These findings indicate that AMD with and without RPD represent mechanistically distinct entities and provide novel insight into the molecular mechanisms underlying disease heterogeneity in AMD.
- Open Access
Genetics of growth rate in induced pluripotent stem cells
Human induced pluripotent stem cells (iPSCs) have transformed biomedical research by enabling the generation of diverse cell types from accessible somatic tissues. However, certain fundamental biological properties, such as the genetic and epigenetic determinants of iPSC proliferation, remain poorly characterized. We measured the growth of iPSC lines derived from 602 unique donors using high-throughput time-lapse imaging, quantified proliferation through a growth Area-Under-the-Curve (gAUC) phenotype, and correlated gAUC with the gene expression and genotype of the cell lines. We identified 3,091 genes associated with gAUC, many of which are well established regulators of cell proliferation. We also found that rare deleterious variants in WDR54 were associated with reduced iPSC growth and that WDR54 was differentially expressed with respect to gAUC. Although no common variants showed a genome-wide association with gAUC, iPSC lines from monozygotic twins were highly correlated, and common genetic variation explained approximately 71-75% of the variance in iPSC growth rates. These results indicate a complex genetic architecture of iPSC growth rates, where rare, large-effect variants in important growth regulators, including WDR54 , are layered onto a highly polygenic background. These findings have important implications for the design of pooled iPSC-based studies and disease models, which may be confounded by intrinsic growth differences.
Open AccessGenetics of growth rate in induced pluripotent stem cells
Human induced pluripotent stem cells (iPSCs) have transformed biomedical research by enabling the generation of diverse cell types from accessible somatic tissues. However, certain fundamental biological properties, such as the genetic and epigenetic determinants of iPSC proliferation, remain poorly characterized. We measured the growth of iPSC lines derived from 602 unique donors using high-throughput time-lapse imaging, quantified proliferation through a growth Area-Under-the-Curve (gAUC) phenotype, and correlated gAUC with the gene expression and genotype of the cell lines. We identified 3,091 genes associated with gAUC, many of which are well established regulators of cell proliferation. We also found that rare deleterious variants in WDR54 were associated with reduced iPSC growth and that WDR54 was differentially expressed with respect to gAUC. Although no common variants showed a genome-wide association with gAUC, iPSC lines from monozygotic twins were highly correlated, and common genetic variation explained approximately 71-75% of the variance in iPSC growth rates. These results indicate a complex genetic architecture of iPSC growth rates, where rare, large-effect variants in important growth regulators, including WDR54 , are layered onto a highly polygenic background. These findings have important implications for the design of pooled iPSC-based studies and disease models, which may be confounded by intrinsic growth differences.
- Open Access
- 4 December 2024
- Published by Springer Nature in Nature Neuroscience
- Vol. 28 (1) , 214
Author Correction: Modeling gene × environment interactions in PTSD using human neurons reveals diagnosis-specific glucocorticoid-induced gene expression
- 4 December 2024
- Published by Springer Nature in Nature Neuroscience
- Vol. 28 (1) , 214
Open AccessAuthor Correction: Modeling gene × environment interactions in PTSD using human neurons reveals diagnosis-specific glucocorticoid-induced gene expression
- Open Access
A repository of Ogden syndrome patient derived iPSC lines and isogenic pairs by X-chromosome screening and genome-editing
Amino-terminal (Nt-) acetylation (NTA) is a common protein modification, affecting 80% of cytosolic proteins in humans. The human essential gene, NAA10, encodes the enzyme NAA10, as the catalytic subunit for the N-terminal acetyltransferase A (NatA) complex, including the accessory protein, NAA15. The first human disease directly involving NAA10 was discovered in 2011, and it was named Ogden syndrome (OS), after the location of the first affected family residing in Ogden, Utah, USA. Since that time, other variants have been found in NAA10 and NAA15. Here we describe the generation of 31 iPSC lines, with 16 from females and 15 from males. This cohort includes CRISPR-mediated correction to the wild-type genotype in 4 male lines, along with editing one female line to generate homozygous wild-type or mutant clones. Following the monoclonalizaiton and screening for X-chromosome activation status in female lines, 3 additional pairs of female lines, in which either the wild type allele is on the active X chromosome (Xa) or the pathogenic variant allele is on Xa, have been generated. Subsets of this cohort have been successfully used to make cardiomyocytes and neural progenitor cells (NPCs). These cell lines are made available to the community via the NYSCF Repository.
Open AccessA repository of Ogden syndrome patient derived iPSC lines and isogenic pairs by X-chromosome screening and genome-editing
Amino-terminal (Nt-) acetylation (NTA) is a common protein modification, affecting 80% of cytosolic proteins in humans. The human essential gene, NAA10, encodes the enzyme NAA10, as the catalytic subunit for the N-terminal acetyltransferase A (NatA) complex, including the accessory protein, NAA15. The first human disease directly involving NAA10 was discovered in 2011, and it was named Ogden syndrome (OS), after the location of the first affected family residing in Ogden, Utah, USA. Since that time, other variants have been found in NAA10 and NAA15. Here we describe the generation of 31 iPSC lines, with 16 from females and 15 from males. This cohort includes CRISPR-mediated correction to the wild-type genotype in 4 male lines, along with editing one female line to generate homozygous wild-type or mutant clones. Following the monoclonalizaiton and screening for X-chromosome activation status in female lines, 3 additional pairs of female lines, in which either the wild type allele is on the active X chromosome (Xa) or the pathogenic variant allele is on Xa, have been generated. Subsets of this cohort have been successfully used to make cardiomyocytes and neural progenitor cells (NPCs). These cell lines are made available to the community via the NYSCF Repository.
- Open Access
Common genetic variation impacts stress response in the brain
To explain why individuals exposed to identical stressors experience divergent clinical outcomes, we determine how molecular encoding of stress modifies genetic risk for brain disorders. Analysis of post-mortem brain (n=304) revealed 8557 stress-interactive expression quantitative trait loci (eQTLs) that dysregulate expression of 915 eGenes in response to stress, and lie in stress-related transcription factor binding sites. Response to stress is robust across experimental paradigms: up to 50% of stress-interactive eGenes validate in glucocorticoid treated hiPSC-derived neurons (n=39 donors). Stress-interactive eGenes show brain region- and cell type-specificity, and, in post-mortem brain, implicate glial and endothelial mechanisms. Stress dysregulates long-term expression of disorder risk genes in a genotype-dependent manner; stress-interactive transcriptomic imputation uncovered 139 novel genes conferring brain disorder risk only in the context of traumatic stress. Molecular stress-encoding explains individualized responses to traumatic stress; incorporating trauma into genomic studies of brain disorders is likely to improve diagnosis, prognosis, and drug discovery. Graphical
Open AccessCommon genetic variation impacts stress response in the brain
To explain why individuals exposed to identical stressors experience divergent clinical outcomes, we determine how molecular encoding of stress modifies genetic risk for brain disorders. Analysis of post-mortem brain (n=304) revealed 8557 stress-interactive expression quantitative trait loci (eQTLs) that dysregulate expression of 915 eGenes in response to stress, and lie in stress-related transcription factor binding sites. Response to stress is robust across experimental paradigms: up to 50% of stress-interactive eGenes validate in glucocorticoid treated hiPSC-derived neurons (n=39 donors). Stress-interactive eGenes show brain region- and cell type-specificity, and, in post-mortem brain, implicate glial and endothelial mechanisms. Stress dysregulates long-term expression of disorder risk genes in a genotype-dependent manner; stress-interactive transcriptomic imputation uncovered 139 novel genes conferring brain disorder risk only in the context of traumatic stress. Molecular stress-encoding explains individualized responses to traumatic stress; incorporating trauma into genomic studies of brain disorders is likely to improve diagnosis, prognosis, and drug discovery. Graphical
- Open Access
- 30 August 2023
- Published by Elsevier in SLAS Technology
- Vol. 29 (3) , 100106
A semi-automated pipeline for quantifying drusen-like deposits in human induced pluripotent stem cell-derived retinal pigment epithelium cells
- 30 August 2023
- Published by Elsevier in SLAS Technology
- Vol. 29 (3) , 100106
Open AccessA semi-automated pipeline for quantifying drusen-like deposits in human induced pluripotent stem cell-derived retinal pigment epithelium cells
- Open Access
- 10 August 2023
- Published by Elsevier in SLAS Discovery
- Vol. 28 (7) , 306-315
FocA: A deep learning tool for reliable, near-real-time imaging focus analysis in automated cell assay pipelines
- 10 August 2023
- Published by Elsevier in SLAS Discovery
- Vol. 28 (7) , 306-315
Open AccessFocA: A deep learning tool for reliable, near-real-time imaging focus analysis in automated cell assay pipelines
- Open Access
FocA: A deep learning tool for reliable, near-real-time imaging focus analysis in automated cell assay pipelines
The increasing use of automation in cellular assays and cell culture presents significant opportunities to enhance the scale and throughput of imaging assays, but to do so, reliable data quality and consistency are critical. Realizing the full potential of automation will thus require the design of robust analysis pipelines that span the entire workflow in question. Here we present FocA, a deep learning tool that, in near real-time, identifies in-focus and out-of-focus images generated on a fully automated cell biology research platform, the NYSCF Global Stem Cell Array®. The tool is trained on small patches of downsampled images to maximize computational efficiency without compromising accuracy, and optimized to make sure no sub-quality images are stored and used in downstream analyses. The tool automatically generates balanced and maximally diverse training sets to avoid bias. The resulting model correctly identifies 100% of out-of-focus and 98% of in-focus images in under 4 seconds per 96-well plate, and achieves this result even in heavily downsampled data (∼30 times smaller than native resolution). Integrating the tool into automated workflows minimizes the need for human verification as well as the collection and usage of low-quality data. FocA thus offers a solution to ensure reliable image data hygiene and improve the efficiency of automated imaging workflows using minimal computational resources.
Open AccessFocA: A deep learning tool for reliable, near-real-time imaging focus analysis in automated cell assay pipelines
The increasing use of automation in cellular assays and cell culture presents significant opportunities to enhance the scale and throughput of imaging assays, but to do so, reliable data quality and consistency are critical. Realizing the full potential of automation will thus require the design of robust analysis pipelines that span the entire workflow in question. Here we present FocA, a deep learning tool that, in near real-time, identifies in-focus and out-of-focus images generated on a fully automated cell biology research platform, the NYSCF Global Stem Cell Array®. The tool is trained on small patches of downsampled images to maximize computational efficiency without compromising accuracy, and optimized to make sure no sub-quality images are stored and used in downstream analyses. The tool automatically generates balanced and maximally diverse training sets to avoid bias. The resulting model correctly identifies 100% of out-of-focus and 98% of in-focus images in under 4 seconds per 96-well plate, and achieves this result even in heavily downsampled data (∼30 times smaller than native resolution). Integrating the tool into automated workflows minimizes the need for human verification as well as the collection and usage of low-quality data. FocA thus offers a solution to ensure reliable image data hygiene and improve the efficiency of automated imaging workflows using minimal computational resources.
- Open Access
A Highly-Efficient, Scalable Pipeline for Fixed Feature Extraction from Large-Scale High-Content Imaging Screens
Leveraging artificial intelligence (AI) in image-based morphological profiling of cell populations is proving increasingly valuable for identifying diseased states and drug responses in high-content imaging (HCI) screens. When the differences between populations (such as a healthy and diseased) are completely unknown and undistinguishable by the human eye, it is crucial that HCI screens are large in scale, allowing numerous replicates for developing reliable models, as well as accounting for confounding factors such as individual (donor) and intra-experimental variation. However, as screen sizes increase, challenges arise including the lack of scalable solutions for analyzing high-dimensional datasets and processing the results in a timely manner. For this purpose, many tools have been developed to reduce images into a set of features using unbiased methods, such as embedding vectors extracted from pre-trained neural networks or autoencoders. While these methods preserve most of the predictive power contained in each image despite reducing the dimensionality significantly, they do not provide easily interpretable information. Alternatively, techniques to extract specific cellular features from data are typically slow, difficult to scale, and often produce redundant outputs, which can lead to the model learning from irrelevant data, which might distort future predictions. Here we present ScaleFEx℠, a memory efficient and scalable open-source Python pipeline that extracts biologically meaningful features from large high-content imaging datasets. It requires only modest computational resources but can also be deployed on high-powered cloud computing infrastructure. ScaleFEx℠ can be used in conjunction with AI models to cluster data and subsequently explore, identify, and rank features to provide insights into the morphological hallmarks of the phenotypic categories. We demonstrate the performance of this tool on a dataset consisting of control and drug-treated cells from a cohort of 20 donors, benchmarking it against the state-of-the-art tool, CellProfiler, and analyze the features underlying the phenotypic shift induced by chemical compounds. In addition, the tools generalizability and utility is shown in the analysis of publicly available datasets. Overall, ScaleFEx℠ constitutes a robust and compact pipeline for identifying the effects of drugs on morphological phenotypes and defining interpretable features that can be leveraged in disease profiling and drug discovery.
Open AccessA Highly-Efficient, Scalable Pipeline for Fixed Feature Extraction from Large-Scale High-Content Imaging Screens
Leveraging artificial intelligence (AI) in image-based morphological profiling of cell populations is proving increasingly valuable for identifying diseased states and drug responses in high-content imaging (HCI) screens. When the differences between populations (such as a healthy and diseased) are completely unknown and undistinguishable by the human eye, it is crucial that HCI screens are large in scale, allowing numerous replicates for developing reliable models, as well as accounting for confounding factors such as individual (donor) and intra-experimental variation. However, as screen sizes increase, challenges arise including the lack of scalable solutions for analyzing high-dimensional datasets and processing the results in a timely manner. For this purpose, many tools have been developed to reduce images into a set of features using unbiased methods, such as embedding vectors extracted from pre-trained neural networks or autoencoders. While these methods preserve most of the predictive power contained in each image despite reducing the dimensionality significantly, they do not provide easily interpretable information. Alternatively, techniques to extract specific cellular features from data are typically slow, difficult to scale, and often produce redundant outputs, which can lead to the model learning from irrelevant data, which might distort future predictions. Here we present ScaleFEx℠, a memory efficient and scalable open-source Python pipeline that extracts biologically meaningful features from large high-content imaging datasets. It requires only modest computational resources but can also be deployed on high-powered cloud computing infrastructure. ScaleFEx℠ can be used in conjunction with AI models to cluster data and subsequently explore, identify, and rank features to provide insights into the morphological hallmarks of the phenotypic categories. We demonstrate the performance of this tool on a dataset consisting of control and drug-treated cells from a cohort of 20 donors, benchmarking it against the state-of-the-art tool, CellProfiler, and analyze the features underlying the phenotypic shift induced by chemical compounds. In addition, the tools generalizability and utility is shown in the analysis of publicly available datasets. Overall, ScaleFEx℠ constitutes a robust and compact pipeline for identifying the effects of drugs on morphological phenotypes and defining interpretable features that can be leveraged in disease profiling and drug discovery.